ArticleMaterials today. Bio2026
Multicellular microtissues from fused ligament- and bone-cell spheroids relevant to enthesis repair.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The enthesis, the point where a tendon or ligament attaches to bone, is a graded fibrocartilaginous interface that poorly regenerates after injury. Here, we present a modular and scaffold-free strategy for engineering microtissues relevant to enthesis repair by fusing anterior cruciate ligament-derived spheroids with spheroids from osteogenically differentiated human mesenchymal stromal cells. We show that the maturation state of the constituent spheroids governs fusion dynamics and spatial organization, enabling the controlled formation of ligament-, fibrocartilage-, and bone-like regions within a single, radially/concentrically organized construct. Within 10 days, the fused tissues display locally distributed lineage-specific markers and type X collagen localized at the interface between the osteogenically-derived core and ligamentous shell. The latter is indicative of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.